Predictive value of post-treatment C-reactive protein-to-albumin ratio in locally advanced non-small cell lung cancer patients receiving durvalumab after chemoradiotherapy.

Thorac Cancer · 2022 · PMC9284133 · PMID 35616056

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

The study revealed that white blood cells (WBC) consistently showed an increasing trend after durvalumab initiation, compared with baseline values, whereas lactate dehydrogenase significantly decreased 3 months after treatment initiation.

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.